EX-CELL(TM) CD CHO Fusion Media Formulation and CHO cGMP Media Library for Cell Culture Applications Now Available
ST. LOUIS, April 9 /PRNewswire-FirstCall/ -- SAFC Biosciences(R), a business segment within SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: SIAL), today announced that it has expanded its portfolio of products and services for use in Chinese Hamster Ovary (CHO) cell line applications with the introduction of EX-CELL(TM) CD CHO Fusion, the Company's next generation chemically defined media formulation, and the CHO cGMP Media Library, an on-the-shelf, media screening library of diverse formulations (http://www.safcbiosciences.com).
EX-CELL CD CHO Fusion media has been specifically developed to work as a scaleable platform media formulation for those cell culture applications requiring a chemically defined animal-component free media option that can meet production requirements across multiple CHO cell lines. This new formulation provides a consistent starting point for such projects as it quickly adapts to the majority of CHO cell lines, providing a platform media option that can reduce timelines and costs typically related to media screening, development and optimization efforts for multiple CHO-based projects.
EX-CELL CD CHO Fusion was developed based on 20 years of CHO media research and development experience and component analysis innovation across legacy JRH Biosciences and Sigma-Aldrich sites, which today make up SAFC Biosciences. This solid track record of experience and technical innovation in this field enables SAFC Biosciences to offer serum-free media support for projects throughout the clinical pipeline - from pre-clinical molecule p
Copyright©2009 PR Newswire.
All rights reserved